Reid Joanne, McKeaveney Clare, Martin Peter
School of Nursing and Midwifery, Queen's University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast, BT9 7BL, UK.
School of Medicine, Geelong Waurn Ponds Campus, Locked Bag 20000, Geelong, VIC, 3220, Australia.
Curr Oncol Rep. 2019 Feb 4;21(2):15. doi: 10.1007/s11912-019-0765-7.
Over the past two decades, advances have been made in understanding the pathophysiology of cancer-associated weight loss, termed "cachexia." To date, there is no proven effective intervention to completely reverse cachexia and there are no approved drug therapies to treat it. This paper will review relevant literature in relation to communicating with adolescents and young adults about cancer-associated weight loss.
Adolescents and young adults (AYAs) who have cancer are a unique group of patients due to their stage of development and maturity. This article outlines issues specific to this patient cohort that need to be considered to better understand the impact of cachexia and explore pertinent matters when communicating with AYAs in relation to cachexia.
在过去二十年里，人们对癌症相关体重减轻（即“恶病质”）的病理生理学的理解取得了进展。迄今为止，尚无经证实有效的干预措施能完全逆转恶病质，也没有获批的药物疗法来治疗它。本文将综述与青少年和青年就癌症相关体重减轻进行沟通的相关文献。
患有癌症的青少年和青年是一类独特的患者群体，这是由于他们的发育阶段和成熟程度所致。本文概述了该患者群体特有的问题，为了更好地理解恶病质的影响，在与青少年和青年就恶病质进行沟通时需要考虑这些问题，并探讨相关事宜。
